SDZ:SWX
Sandoz Group AG
CHF 71.02
arrow_upward
+1.46%(+1.02) 1D
Oct 6, 10:06:49 AM GMT+2 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SDZ...
Open
CHF 70.72
High
CHF 71.38
Low
CHF 70.50
Mkt. cap
31.17B
Avg. vol.
1.61M
Volume
124.32K
Dividend
1.13%
Quarterly dividend
CHF 0.20
Ex-dividend date
Apr 13, 2026
P/E ratio
58.10
52-wk high
CHF 75.90
52-wk low
CHF 46.77
EPS
CHF 1.22
Shares outstanding
440.00M
No. of employees
20K
Open
CHF 70.72
High
CHF 71.38
Low
CHF 70.50
Mkt. cap
31.17B
Avg. vol.
1.61M
Volume
124.32K
Dividend
1.13%
Quarterly dividend
CHF 0.20
Ex-dividend date
Apr 13, 2026
P/E ratio
58.10
52-wk high
CHF 75.90
52-wk low
CHF 46.77
EPS
CHF 1.22
Shares outstanding
440.00M
No. of employees
20K
News stories
From web sources and news partners
Profile
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
About Sandoz Group AG